Literature DB >> 25035098

Spinal cord infarction in giant cell arteritis associated with scalp necrosis.

Khader N Mustafa1, Azmy Hadidy, Anwar Joudeh, Fatima Nouri Obeidat, Khalid W Abdulfattah.   

Abstract

Spinal cord infarction is extremely rare in patients with giant cell arteritis (GCA). There are only four case reports in the literature. We describe a 65-year-old man who presented with sudden paraplegia and back pain of 4-days duration with sensory loss below the umbilicus and bilateral scalp necrosis. Magnetic resonance imaging finding was consistent with dorsal spinal cord infarction. Biopsy of the temporal artery confirmed the diagnosis of GCA. The patient was treated with high dose of corticosteroids, which resulted in healing of the scalp ulcerations in 3 weeks, but the paraplegia was irreversible. To our knowledge, this is the first report of spinal cord infarction and simultaneous occurrence of bilateral scalp necrosis in a histopathologically proven GCA. Although literature about spinal cord involvement in GCA is very limited, cord infarction is associated with high mortality and therapeutic challenges since little is understood regarding the pathogenesis that leads to infarction.

Entities:  

Mesh:

Year:  2014        PMID: 25035098     DOI: 10.1007/s00296-014-3089-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Giant cell arteritis involving the mesenteric arteries.

Authors:  Maha Abdul Azeez; Peter Browne; Paul O'Connell; Derval Roysten
Journal:  J Rheumatol       Date:  2009-10       Impact factor: 4.666

2.  Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.

Authors:  C Font; M C Cid; B Coll-Vinent; A López-Soto; J M Grau
Journal:  Br J Rheumatol       Date:  1997-02

3.  Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.

Authors:  Miguel A Gonzalez-Gay; Sonia Barros; Maria J Lopez-Diaz; Carlos Garcia-Porrua; Amalia Sanchez-Andrade; Javier Llorca
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

4.  Giant cell arteritis with spinal cord infarction and basilar artery thrombosis.

Authors:  W R Gibb; P A Urry; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

5.  Reversible quadriplegia in a patient with giant-cell arteritis.

Authors:  M J Brennan; R Sandyk
Journal:  S Afr Med J       Date:  1982-07-17

6.  [Highly located transverse lesion of the cord with quadriplegia caused by giant cell arteritis (author's transl)].

Authors:  W D Engelke; D Dörstelmann
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1979-02

7.  Spinal cord infarction: etiology and outcome.

Authors:  W P Cheshire; C C Santos; E W Massey; J F Howard
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

8.  Large artery involvement in giant cell (temporal) arteritis.

Authors:  R G Klein; G G Hunder; A W Stanson; S G Sheps
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

9.  Giant cell arteritis complicated by spinal cord infarction: a therapeutic dilemma.

Authors:  Oren Fruchter; Haim Ben-Ami; Daniel Schapira; Zahava Gallimidi; Diana Gaitini; Dorit Goldsher
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

10.  Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.

Authors:  Dirk M Nuenninghoff; Gene G Hunder; Teresa J H Christianson; Robyn L McClelland; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2003-12
View more
  1 in total

Review 1.  Neurologic manifestations of giant cell arteritis.

Authors:  Antoine Soulages; Igor Sibon; Jean-Michel Vallat; Emmanuel Ellie; Frédéric Bourdain; Fanny Duval; Louis Carla; Marie-Laure Martin-Négrier; Guilhem Solé; Charles Laurent; Agnès Monnier; Gwendal Le Masson; Stéphane Mathis
Journal:  J Neurol       Date:  2022-02-06       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.